https://www.selleckchem.com/products/shr0302.html
ing CA and therefore, more inclined to chronic migraine. In the new pharmacological scenario, it would be useful to address therapeutic resources to specific migraine populations with a high risk of more severe clinical phenotype.Background Few studies have focused on risk stratification for premature death after transplantation. However, stratification of individual risk is an essential step in personalized care. Material and methods We have developed a risk score of early post-transplant death (ORLY score) in a prospective multicentre
Like
Comment
Share
